Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients

[1]  N. Pannu,et al.  Risk Prediction Models for Contrast-Induced Acute Kidney Injury Accompanying Cardiac Catheterization: Systematic Review and Meta-analysis. , 2017, The Canadian journal of cardiology.

[2]  A. Shahidzadeh,et al.  Strategies Preventing Contrast-Induced Nephropathy After Coronary Angiography: A Comprehensive Meta-Analysis and Systematic Review of 125 Randomized Controlled Trials , 2017, Angiology.

[3]  J. Wildberger,et al.  Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial , 2017, The Lancet.

[4]  Lang Li,et al.  Clinical effect of trimetazidine on prevention of contrast-induced nephropathy in patients with renal insufficiency , 2017, Medicine.

[5]  F. Song,et al.  Comparative Effectiveness of 12 Treatment Strategies for Preventing Contrast-Induced Acute Kidney Injury: A Systematic Review and Bayesian Network Meta-analysis. , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  R. Vanholder,et al.  Statins for the prevention of contrast-induced acute kidney injury , 2016, Current opinion in nephrology and hypertension.

[7]  Lang Li,et al.  The effect of alprostadil on preventing contrast-induced nephropathy for percutaneous coronary intervention in diabetic patients , 2016, Medicine.

[8]  L. Bergamasco,et al.  AKIGUARD (Acute Kidney Injury GUARding Device) trial: in-hospital and one-year outcomes , 2016, Journal of cardiovascular medicine.

[9]  G. Stone,et al.  Statin use prior to angiography for the prevention of contrast-induced acute kidney injury: a meta-analysis of 19 randomised trials. , 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[10]  S. Raposeiras-Roubín,et al.  Mehran contrast nephropathy risk score: Is it still useful 10 years later? , 2016, Journal of cardiology.

[11]  K. Phan,et al.  Periprocedural effects of statins on the incidence of contrast-induced acute kidney injury: A systematic review and trial sequential analysis. , 2016, International journal of cardiology.

[12]  G. Cheng,et al.  Efficacy of Short-Term Statin Treatment for the Prevention of Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Angiography/Percutaneous Coronary Intervention: A Meta-Analysis of 21 Randomized Controlled Trials , 2016, American Journal of Cardiovascular Drugs.

[13]  Renee F Wilson,et al.  Effectiveness of Prevention Strategies for Contrast-Induced Nephropathy , 2016, Annals of Internal Medicine.

[14]  Yundai Chen,et al.  Prevention of Contrast-Induced Nephropathy by Central Venous Pressure-Guided Fluid Administration in Chronic Kidney Disease and Congestive Heart Failure Patients. , 2016, JACC. Cardiovascular interventions.

[15]  R. Loomba,et al.  Role of N-Acetylcysteine to Prevent Contrast-Induced Nephropathy: A Meta-analysis , 2016, American journal of therapeutics.

[16]  K. Poh,et al.  Comparison of combination therapy of high-dose oral N-acetylcysteine and intravenous sodium bicarbonate hydration with individual therapies in the reduction of Contrast-induced Nephropathy during Cardiac Catheterisation and Percutaneous Coronary Intervention (CONTRAST): A multi-centre, randomised, c , 2015, International journal of cardiology.

[17]  A. Sato,et al.  Effect of the Mehran risk score for the prediction of clinical outcomes after percutaneous coronary intervention. , 2015, Journal of cardiology.

[18]  A. Briasoulis,et al.  3-Hydroxy-3-Methylglutaryl-CoA Reductase Enzyme Inhibitors for Prevention of Contrast-Induced Nephropathy: A Meta-Analysis of Prospective Randomized Controlled Studies , 2015, American journal of therapeutics.

[19]  Xin Kang,et al.  N-acetylcysteine for the prevention of contrast-induced nephropathy in patients with pre-existing renal insufficiency or diabetes: a systematic review and meta-analysis , 2015, Renal failure.

[20]  C. Thongprayoon,et al.  Periprocedural Nebivolol for the Prevention of Contrast-Induced Acute Kidney Injury: A Systematic Review and Meta-analysis , 2015, North American journal of medical sciences.

[21]  J. DiNicolantonio,et al.  Systematic oral hydration with water is similar to parenteral hydration for prevention of contrast-induced nephropathy: an updated meta-analysis of randomised clinical data , 2015, Open Heart.

[22]  Y. Ho,et al.  Nephrotoxic Polypharmacy and Risk of Contrast Medium-Induced Nephropathy in Hospitalized Patients Undergoing Contrast-Enhanced CT. , 2015, AJR. American journal of roentgenology.

[23]  A. Jeremias,et al.  Randomized Trial of Bicarbonate or Saline Study for the Prevention of Contrast-Induced Nephropathy in Patients with CKD. , 2015, Clinical journal of the American Society of Nephrology : CJASN.

[24]  T. Murphy,et al.  Fenoldopam for the prevention of contrast-induced nephropathy (CIN)-do we need more trials? A meta-analysis. , 2015, Clinical imaging.

[25]  Z. Harel,et al.  Risk prediction models for contrast induced nephropathy: systematic review , 2015, BMJ : British Medical Journal.

[26]  J. Bilbao,et al.  Comparison of Intravenous and Oral Hydration in the Prevention of Contrast-Induced Acute Kidney Injury in Low-Risk Patients: A Randomized Trial , 2015, Nephron.

[27]  Jeremiah R. Brown,et al.  A Review of the Use of Iloprost, A Synthetic Prostacyclin, in the Prevention of Radiocontrast Nephropathy in Patients Undergoing Coronary Angiography and Intervention , 2015, Clinical cardiology.

[28]  S. Mehta,et al.  Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patie , 2015, American heart journal.

[29]  W. Ng,et al.  Screening for impaired renal function in outpatients before iodinated contrast injection: Comparing the Choyke questionnaire with a rapid point-of-care-test. , 2015, European journal of radiology.

[30]  Yan-xian Wu,et al.  Rosuvastatin Treatment for Preventing Contrast-Induced Acute Kidney Injury After Cardiac Catheterization , 2015, Medicine.

[31]  Ruiyan Zhang,et al.  The Effect of Renin-Angiotensin-Aldosterone System Blockade Medications on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography: A Meta-Analysis , 2015, PloS one.

[32]  M. Velázquez,et al.  Role of hydration in contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention. , 2015, The American journal of cardiology.

[33]  G. Bongartz,et al.  Serum creatinine measurements: evaluation of a questionnaire according to the ESUR guidelines , 2015, Acta radiologica.

[34]  S. Erickson,et al.  Periprocedural effects of statins on the incidence of contrast-induced acute kidney injury: a systematic review and meta-analysis of randomized controlled trials , 2015, Renal failure.

[35]  J. Werba,et al.  A meta-analysis of randomized controlled trials on statins for the prevention of contrast-induced acute kidney injury in patients with and without acute coronary syndromes. , 2015, International journal of cardiology.

[36]  W. Niu,et al.  Impact of Renin-Angiotensin-Aldosterone System-blocking Agents on the Risk of Contrast-induced Acute Kidney Injury: A Prospective Study and Meta-analysis , 2015, Journal of cardiovascular pharmacology.

[37]  N. Tan,et al.  Statins for the Prevention of Contrast-Induced Nephropathy After Coronary Angiography/Percutaneous Interventions , 2015, Journal of cardiovascular pharmacology and therapeutics.

[38]  F. Javed,et al.  Trimetazidine Decreases Risk of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease , 2015, Journal of cardiovascular pharmacology and therapeutics.

[39]  Dongmei Li,et al.  Meta‐analysis of short‐term high versus low doses of atorvastatin preventing contrast‐induced acute kidney injury in patients undergoing coronary angiography/percutaneous coronary intervention , 2015, Journal of clinical pharmacology.

[40]  Silvio E. Inzucchi,et al.  Metformin in patients with type 2 diabetes and kidney disease: a systematic review. , 2014, JAMA.

[41]  D. Matthews,et al.  Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes , 2014, Diabetes Care.

[42]  S. Erickson,et al.  Oral Hydration for Prevention of Contrast-Induced Acute Kidney Injury in Elective Radiological Procedures: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2014, North American journal of medical sciences.

[43]  Michael E. Matheny,et al.  Validated Contemporary Risk Model of Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions: Insights From the National Cardiovascular Data Registry Cath‐PCI Registry , 2014, Journal of the American Heart Association.

[44]  J. Hamming,et al.  Abstract 17645: Randomized Trial of 1-hour Sodium Bicarbonate Vs. Standard Saline Hydration in Patients With Chronic Kidney Disease Undergoing Intra-arterial Contrast Administration , 2014 .

[45]  Hyo‐Soo Kim,et al.  The Impact of Renin-Angiotensin-Aldosterone System Blockade on Contrast-Induced Nephropathy: A Meta-Analysis of 12 Studies with 4,493 Patients , 2014, Cardiology.

[46]  N. Çam,et al.  Efficacy of Oral Hydration in the Prevention of Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Angiography or Intervention , 2014, Nephron Clinical Practice.

[47]  J. Noh,et al.  The prevention of contrast-induced nephropathy by simultaneous hemofiltration during coronary angiographic procedures: a comparison with periprocedural hemofiltration. , 2014, International journal of cardiology.

[48]  H. Putter,et al.  Randomised trial of no hydration vs. sodium bicarbonate hydration in patients with chronic kidney disease undergoing acute computed tomography–pulmonary angiography , 2014, Journal of thrombosis and haemostasis : JTH.

[49]  A. Caixeta,et al.  Do Intravenous N-Acetylcysteine and Sodium Bicarbonate Prevent High Osmolal Contrast-Induced Acute Kidney Injury? A Randomized Controlled Trial , 2014, PloS one.

[50]  D. Capodanno,et al.  Meta-analysis of randomized controlled trials of preprocedural statin administration for reducing contrast-induced acute kidney injury in patients undergoing coronary catheterization. , 2014, The American journal of cardiology.

[51]  H. Gurm,et al.  Predicting Contrast-induced Renal Complications in the Catheterization Laboratory. , 2014, Interventional cardiology clinics.

[52]  J. Stoker,et al.  Cost of screening strategies for kidney disease before intravenous contrast administration. , 2014, The Netherlands journal of medicine.

[53]  E. Dervişoğlu,et al.  Comparison of short-term infusion regimens of N-acetylcysteine plus intravenous fluids, sodium bicarbonate plus intravenous fluids, and intravenous fluids alone for prevention of contrast-induced nephropathy in the emergency department. , 2014, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[54]  Somjot S. Brar,et al.  Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial , 2014, The Lancet.

[55]  F. Richy,et al.  Incidence of Lactic Acidosis in Patients With Type 2 Diabetes With and Without Renal Impairment Treated With Metformin: A Retrospective Cohort Study , 2014, Diabetes Care.

[56]  Suraj Khanal.  Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease. , 2014 .

[57]  J. Kaski,et al.  Validation of a new risk score to predict contrast-induced nephropathy after percutaneous coronary intervention. , 2014, The American journal of cardiology.

[58]  J. Hamming,et al.  A randomized comparison of 1-h sodium bicarbonate hydration versus standard peri-procedural saline hydration in patients with chronic kidney disease undergoing intravenous contrast-enhanced computerized tomography. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[59]  Yu Luo,et al.  Remedial hydration reduces the incidence of contrast-induced nephropathy and short-term adverse events in patients with ST-segment elevation myocardial infarction: a single-center, randomized trial. , 2014, Internal medicine.

[60]  H. Thomsen,et al.  Can a structured questionnaire identify patients with reduced renal function? , 2014, European Radiology.

[61]  J. Gillard,et al.  Does ascorbic acid protect against contrast-induced acute kidney injury in patients undergoing coronary angiography: a systematic review with meta-analysis of randomized, controlled trials. , 2013, Journal of the American College of Cardiology.

[62]  J. Kellum,et al.  N-acetylcysteine plus intravenous fluids versus intravenous fluids alone to prevent contrast-induced nephropathy in emergency computed tomography. , 2013, Annals of emergency medicine.

[63]  S. Walsh,et al.  The Role of N--Acetylcysteine in the Prevention of Contrast-Induced Nephropathy in Patients Undergoing Peripheral Angiography , 2013, Angiology.

[64]  O. Oliyarnyk,et al.  Prevention of contrast-induced nephropathy in diabetic patients with impaired renal function: a randomized, double blind trial of sodium bicarbonate versus sodium chloride-based hydration. , 2013, Diabetes research and clinical practice.

[65]  J. Stoker,et al.  Contrast induced nephropathy in patients undergoing intravenous (IV) contrast enhanced computed tomography (CECT) and the relationship with risk factors: a meta-analysis. , 2013, European journal of radiology.

[66]  R. Ekart,et al.  Ascorbic Acid for the Prevention of Contrast‐Induced Nephropathy After Coronary Angiography in Patients With Chronic Renal Impairment: A Randomized Controlled Trial , 2013, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[67]  Ya Miao,et al.  Alprostadil plays a protective role in contrast-induced nephropathy in the elderly , 2013, International Urology and Nephrology.

[68]  H. Gurm,et al.  A novel tool for reliable and accurate prediction of renal complications in patients undergoing percutaneous coronary intervention. , 2013, Journal of the American College of Cardiology.

[69]  T. Perneger,et al.  N-acetylcysteine does not prevent contrast nephropathy in patients with renal impairment undergoing emergency CT: a randomized study , 2013, BMC Nephrology.

[70]  A. Çelik,et al.  Sodium Bicarbonate Versus Isotonic Saline for the Prevention of Contrast-Induced Nephropathy in Patients With Diabetes Mellitus Undergoing Coronary Angiography and/or Intervention , 2013, Journal of Investigative Medicine.

[71]  A. Boening,et al.  Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial. , 2013, The Journal of invasive cardiology.

[72]  E. Victor,et al.  Acetylcysteine for the Prevention of Renal Outcomes in Patients With Diabetes Mellitus Undergoing Coronary and Peripheral Vascular Angiography: A Substudy of the Acetylcysteine for Contrast-Induced Nephropathy Trial , 2013, Circulation. Cardiovascular interventions.

[73]  W. Shabana,et al.  Prevention of Contrast-Induced Acute Kidney Injury: Is Simple Oral Hydration Similar To Intravenous? A Systematic Review of the Evidence , 2013, PloS one.

[74]  H. Tamim,et al.  Efficacy of ascorbic acid, N-acetylcysteine, or combination of both on top of saline hydration versus saline hydration alone on prevention of contrast-Induced nephropathy: a prospective randomized study. , 2013, Journal of interventional cardiology.

[75]  Zhiliang Li,et al.  Intravenous N-Acetylcysteine for Prevention of Contrast-Induced Nephropathy: A Meta-Analysis of Randomized, Controlled Trials , 2013, PloS one.

[76]  Airton O. Arruda,et al.  Hydration with sodium bicarbonate does not prevent contrast nephropathy: a multicenter clinical trial. , 2012, Arquivos brasileiros de cardiologia.

[77]  Zhang Shufeng,et al.  PROTECTIVE EFFECTS OF ERYTHROPOIETIN ON CARDIAC FUNCTION IN DIABETIC RATS , 2012, Heart.

[78]  S. Belknap,et al.  Comparison of the sensitivity of a pre-MRI questionnaire and point of care eGFR testing for detection of impaired renal function. , 2012, Academic Radiology.

[79]  Le-Xin Wang,et al.  Comparison of oral and intravenous hydration strategies for the prevention of contrast-induced nephropathy in patients undergoing coronary angiography or angioplasty: a randomized clinical trial , 2012, Acta cardiologica.

[80]  Hui-ru Chen,et al.  PREVENTION OF CONTRAST-INDUCED NEPHROPATHY WITH ASCORBIC ACID , 2012, Heart.

[81]  B. Dai,et al.  Effect of theophylline on prevention of contrast-induced acute kidney injury: a meta-analysis of randomized controlled trials. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[82]  F. Maklady,et al.  Effectiveness of theophylline in preventing contrast-induced nephropathy after coronary angiographic procedures. , 2012, Journal of interventional cardiology.

[83]  H. Oflaz,et al.  Intrarenal application of N-acetylcysteine for the prevention of contrast medium-induced nephropathy in primary angioplasty , 2012, Coronary artery disease.

[84]  J. Jenkins,et al.  A randomized trial of intravenous N‐acetylcysteine to prevent contrast induced nephropathy in acute coronary syndromes , 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[85]  S. Allaqaband,et al.  Prevention of contrast‐induced acute kidney injury in patients with stable chronic renal disease undergoing elective percutaneous coronary and peripheral interventions: Randomized comparison of two preventive strategies , 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[86]  C. Schindler,et al.  Sodium chloride vs. sodium bicarbonate for the prevention of contrast medium-induced nephropathy: a randomized controlled trial. , 2012, European heart journal.

[87]  C. Ronco,et al.  Renal replacement therapies for prevention of radiocontrast-induced nephropathy: a systematic review. , 2012, The American journal of medicine.

[88]  F. Veglia,et al.  Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial. , 2012, JACC. Cardiovascular interventions.

[89]  M. Valgimigli,et al.  Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in High-Risk Patients for Contrast-Induced Acute Kidney Injury , 2011, Circulation.

[90]  P. Aspelin,et al.  Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines , 2011, European Radiology.

[91]  I. Seong,et al.  Preventive strategies of renal insufficiency in patients with diabetes undergoing intervention or arteriography (the PREVENT Trial). , 2011, The American journal of cardiology.

[92]  Gordon H Guyatt,et al.  GRADE guidelines: 2. Framing the question and deciding on important outcomes. , 2011, Journal of clinical epidemiology.

[93]  Michelle E. Kho,et al.  AGREE II: advancing guideline development, reporting and evaluation in health care , 2010, Canadian Medical Association Journal.

[94]  P. Caramori,et al.  Há uma associação entre anti-inflamatórios não-esteroides e nefropatia induzida por contraste? , 2010 .

[95]  Gene Feder,et al.  AGREE II: advancing guideline development, reporting and evaluation in health care. , 2010, Journal of clinical epidemiology.

[96]  G. Carvalhal,et al.  Is there an association between non-steroidal anti-inflammatory drugs and contrast nephropathy? , 2010, Arquivos brasileiros de cardiologia.

[97]  Shan Jiang,et al.  Renal Replacement Therapy for Prevention of Contrast-Induced Acute Kidney Injury: A Meta-Analysis of Randomized Controlled Trials , 2010, American Journal of Nephrology.

[98]  Oral hydration and alkalinization is noninferior to intravenous therapy for prevention of contrast-induced nephropathy in patients with chronic kidney disease. , 2010, Journal of interventional cardiology.

[99]  G. Sangiorgi,et al.  Mehran Contrast-Induced Nephropathy Risk Score Predicts Short- and Long-Term Clinical Outcomes in Patients With ST-Elevation–Myocardial Infarction , 2010, Circulation. Cardiovascular interventions.

[100]  P. Vojtíšek,et al.  Prevention of contrast-induced acute kidney injury by theophylline in elderly patients with chronic kidney disease , 2010, Heart and Vessels.

[101]  W. Wróbel,et al.  Oral versus intravenous hydration and renal function in diabetic patients undergoing percutaneous coronary interventions. , 2010, Kardiologia polska.

[102]  M. Khamaisi,et al.  Reactive Oxygen Species and the Pathogenesis of Radiocontrast-Induced Nephropathy , 2010, Investigative radiology.

[103]  F. Lombardi,et al.  Prevention of Contrast‐induced Nephropathy: A Single Center Randomized Study , 2010, Clinical cardiology.

[104]  I. Harris,et al.  A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2010 .

[105]  S. Goergen,et al.  Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin. , 2010, Radiology.

[106]  I. Slotki,et al.  Sodium bicarbonate versus sodium chloride and oral N-acetylcysteine for the prevention of contrast-induced nephropathy in advanced chronic kidney disease. , 2009, Journal of interventional cardiology.

[107]  S. Bergmann,et al.  Prevention of contrast-induced nephropathy: A randomized controlled trial of sodium bicarbonate and N-acetylcysteine , 2009, The International journal of angiology : official publication of the International College of Angiology, Inc.

[108]  Jeremiah R. Brown,et al.  Sodium bicarbonate plus N-acetylcysteine prophylaxis: a meta-analysis. , 2009, JACC. Cardiovascular interventions.

[109]  Samin K. Sharma,et al.  N-Acetylcysteine added to volume expansion with sodium bicarbonate does not further prevent contrast-induced nephropathy: results from the cardiac angiography in renally impaired patients study. , 2009, Journal of interventional cardiology.

[110]  T. Walker.  Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: A prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine , 2009 .

[111]  A. Elster.  Sodium Bicarbonate vs Sodium Chloride for the Prevention of Contrast Medium–Induced Nephropathy in Patients Undergoing Coronary Angiography: A Randomized Trial , 2009 .

[112]  B. Souweine,et al.  Is treatment with N-acetylcysteine to prevent contrast-induced nephropathy when using bicarbonate hydration out of date? , 2008, Clinical nephrology.

[113]  C. Nienaber,et al.  Renal Insufficiency Following Radiocontrast Exposure Trial (REINFORCE): a randomized comparison of sodium bicarbonate versus sodium chloride hydration for the prevention of contrast-induced nephropathy , 2008, Coronary artery disease.

[114]  M. Leoncini,et al.  Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. , 2008, Journal of the American College of Cardiology.

[115]  Jun-Jie Zhang,et al.  Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine. , 2008, International journal of cardiology.

[116]  M. Devita,et al.  The effect of withdrawal of ACE inhibitors or angiotensin receptor blockers prior to coronary angiography on the incidence of contrast-induced nephropathy , 2008, International Urology and Nephrology.

[117]  L. Moist,et al.  Prevention of contrast-induced nephropathy in vascular surgery patients. , 2007, Annals of vascular surgery.

[118]  T. Morita,et al.  Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure. , 2007, The American journal of cardiology.

[119]  O. Aslan,et al.  Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial. , 2007, American heart journal.

[120]  J. Kaski,et al.  The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study. , 2007, Journal of the American College of Cardiology.

[121]  A. Colombo,et al.  Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): A Randomized Comparison of 3 Preventive Strategies , 2007, Circulation.

[122]  J. Núñez,et al.  Intravenous N-acetylcysteine for preventing contrast-induced nephropathy: a randomised trial. , 2007, International journal of cardiology.

[123]  G. Breithardt,et al.  A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy: the Dialysis-versus-Diuresis (DVD) Trial. , 2007, Clinical research in cardiology : official journal of the German Cardiac Society.

[124]  S. Weisbord,et al.  The effect of coronary angiography on residual renal function in patients on peritoneal dialysis , 2006, Clinical cardiology.

[125]  R. Bellomo,et al.  Extracorporeal blood purification therapies for prevention of radiocontrast-induced nephropathy: a systematic review. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[126]  P. Auquier,et al.  A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[127]  M. Perazella.  Drug-induced nephropathy: an update , 2005, Expert opinion on drug safety.

[128]  G. Stone,et al.  A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. , 2004, Journal of the American College of Cardiology.

[129]  R. Bersin,et al.  Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. , 2004, JAMA.

[130]  G. Colucci,et al.  Does Continuous Venovenous Hemodiafiltration Concomitant with Radiological Procedures Provide a Significant and Safe Removal of the Iodinated Contrast Ioversol? , 2003, Blood Purification.

[131]  A. Agrawal,et al.  A Randomized Prospective Trial to Assess the Role of Saline Hydration on the Development of Contrast Nephrotoxicity , 2003, Nephron Clinical Practice.

[132]  E. Salpeter,et al.  Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. , 2003, The Cochrane database of systematic reviews.

[133]  H. Yoshimoto,et al.  Time-course of iodine elimination by hemodialysis in patients with renal failure after angiography. , 2002, Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis.

[134]  H. Thomsen,et al.  Dialysis and contrast media , 2002, European Radiology.

[135]  D. Baumgarten,et al.  Are screening serum creatinine levels necessary prior to outpatient CT examinations? , 2000, Radiology.

[136]  H. Thomsen,et al.  Contrast media and metformin: guidelines to diminish the risk of lactic acidosis in non-insulin-dependent diabetics after administration of contrast media , 1999, European Radiology.

[137]  Allen J. Taylor,et al.  Clinical InvestigationsCardiologyPREPARED: PREParation for Angiography in REnal Dysfunction: A Randomized Trial of Inpatient vs Outpatient Hydration Protocols for Cardiac Catheterization in Mild-to-Moderate Renal Dysfunction , 1998 .

[138]  P. Choyke,et al.  Determination of serum creatinine prior to iodinated contrast media: is it necessary in all patients? , 1998, Techniques in urology.

[139]  J. Kaude,et al.  Dialysis is not indicated immediately after administration of nonionic contrast agents in patients with end-stage renal disease treated by maintenance dialysis. , 1994, AJR. American journal of roentgenology.